It is proposed to investigate the synthetic, mechanistic and theoretical aspects of polyene chemistry as they relate to both the chemistry and biology of vitamins A (retinoids) and D (calciferols). Besides their role in vision and in the energy transduction process of Halobacterium halobium, the retinoids are of interest in the treatment of certain dermatological diseases and, like vitamin D, in cell differentiation and proliferation as related to cancer chemoprevention. 1Alpha, 25-Dihydroxyvitamin D3 (1Alpha, 25-(OH)2-D3), the hormonally active form of vitamin D, is also of intense interst in terms of disease stats (e.g., osteoporosis) associated with abnormalities in calcium metabolism. The long-range goal of this research is to develop an understanding at the molecular level of the biochemical mode-of-action of these polyenes as they traverse the endocrine maze. Such a detailed understanding of the mechanism of action of these bioactive polyenes is expected to lead to a more precise and practical approach to the treatment of vitamin A- and vitamin D-related metabolic disorders.
The aims i nclude: systematic mechanistic and synthetic investigations of thermal (1,5)-sigmatropic shifts of vinyl-allenes as well as cyclopropylallenes related to vitamins A and D and model systems; a detailed investigation of thermal, antarafacial (1,7)-sigmatropic shifts through isotopic labeling and structural variation studies and an evaluation of the relationship of the results to the biological significance of previtamin D3 and the biosynthesis of vitamin D3; the development of a strategicaly unique seco-C-ring strategy for the formal total sysnthesis of vitamin D analogues and metabolites; studies of allenic anions and dianions pertinent to the diastereoselective synthesis of chiral allenes, useful synthetic intermediates for vitamin A and D syntheses; develop the synthesis of analogues of vitamins A and D via thermal isomerizations of vinylallenes and other polyenes; in the retinoids aresa, studies of visual pigment analogues and model systems as well as structure-activity studies of appropriate substrates in inducing cell differentiation and proliferation; and, in the calciferol area, studies of agonists and antagonists of 1 alpha, 25-(OH)2-D3 at the chick intestinal receptor level, the purification of this receptor and the design of inhibitors of enzymes involved in vitamin D metabolism, particularly at the renal level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK016595-17
Application #
3225605
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1977-04-01
Project End
1992-03-31
Budget Start
1990-04-01
Budget End
1992-03-31
Support Year
17
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California Riverside
Department
Type
Schools of Earth Sciences/Natur
DUNS #
City
Riverside
State
CA
Country
United States
Zip Code
92521
Okamura, William H; Zhu, Gui-Dong; Hill, David K et al. (2002) Synthesis and NMR studies of (13)C-labeled vitamin D metabolites. J Org Chem 67:1637-50
Hayashi, Rena; Fernandez, Susana; Okamura, William H (2002) An 8pi electron electrocyclization leading to a 9,19-methano-bridged analogue of 1 alpha,25-dihydroxyvitamin D3. Org Lett 4:851-4
Norman, Anthony W; Okamura, William H; Bishop, June E et al. (2002) Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3. Mol Cell Endocrinol 197:1-13
Okamura, W H; Do, S; Kim, H et al. (2001) Conformationally restricted mimics of vitamin D rotamers. Steroids 66:239-47
Norman, A W; Manchand, P S; Uskokovic, M R et al. (2000) Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. J Med Chem 43:2719-30
Norman, A W; Song, X; Zanello, L et al. (1999) Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2vitamin D3. Steroids 64:120-8
Song, X; Bishop, J E; Okamura, W H et al. (1998) Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 139:457-65
Norman, A W; Okamura, W H; Hammond, M W et al. (1997) Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for ge Mol Endocrinol 11:1518-31
Muralidharan, K R; Rowland-Goldsmith, M; Lee, A S et al. (1997) Inhibitors of 25-hydroxyvitamin D3-1alpha-hydroxylase: thiavitamin D analogs and biological evaluation. J Steroid Biochem Mol Biol 62:73-8
Norman, A W; Bishop, J E; Collins, E D et al. (1996) Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. J Steroid Biochem Mol Biol 56:13-22

Showing the most recent 10 out of 24 publications